MAD2L1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB300-880
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Canine (100%), Mouse (100%), Porcine (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-KVNSMVAYKIPVND corresponding to C-Terminus according to NP_002349.1.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for MAD2L1 Antibody
Western Blot: MAD2L1 Antibody [NB300-880]
Western Blot: Mad2L1 Antibody [NB300-880] - Analysis of Mad2L1 in HEK293 lysate (35ug protein in RIPA buffer) using NB300-880 at 2ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.Applications for MAD2L1 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:32000
Western Blot
2 - 4 ug/ml
Application Notes
WB: Approx. 24 kDa band observed in HEK293 lysates (calculated MW of 23.5 kDa band according to NP_002349.1). An additional band of unknown identity was also consistently observed at approx. 29 kDa. This band was successfully blocked by incubation with the immunizing peptide.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: MAD2L1
Long Name
MAD2 Mitotic Arrest Deficient-Like 1
Alternate Names
HSMAD2
Gene Symbol
MAD2L1
UniProt
Additional MAD2L1 Products
Product Documents for MAD2L1 Antibody
Product Specific Notices for MAD2L1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...